Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium channels in the central nervous system are transmembrane proteins responsible for the initiation and propagation of action potentials in neurons, playing a critical role in electrical signaling[1][2][3]. They are large complexes composed of a core α (alpha) subunit—which forms the ion-conducting pore and determines isoform specificity—together with auxiliary β subunits that affect channel kinetics and localization[1][2]. The α subunit contains four homologous domains (I–IV), each with six transmembrane segments (S1–S6)[1][2][3]. The S4 segment acts as the voltage sensor; S5 and S6 (and the connecting loop) define the pore[1][2][3]. Activation by membrane depolarization opens the channel, allowing an influx of Na⁺ ions, which depolarizes the neuron and mediates the upstroke of the action potential[1][2][3][4]. In CNS neurons, several Nav channel subtypes (including Nav1.1/SCN1A, Nav1.2/SCN2A, Nav1.3/SCN3A, and Nav1.6/SCN8A) are expressed, each with distinct physiological and pathophysiological roles[1][2][4]. Central nervous system sodium channels are key targets for multiple antiepileptic drugs and local anesthetics, which inhibit channel function by stabilizing inactive states and reducing abnormal firing[2][3]. Genetic mutations in CNS channel subtypes are linked to a range of neurological channelopathies, including epilepsy, ataxia, and neurodevelopmental disorders[4].
Blockade of sodium ion conductance through the channel pore; Stabilization of the inactivated state (use-dependent block); Alteration of channel gating kinetics; Inhibition of repetitive neuronal firing
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated sodium channel (central nervous system subtype) (VGSC (Nav channel); no single abbreviation for CNS-wide channel, but subtypes are denoted as Nav1.1, Nav1.2, etc.).